| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS631774 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS633428 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS633584 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS634132 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS634545 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS635762 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS636340 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS637896 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS637907 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS638261 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS639596 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS639669 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS640366 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS642303 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS644560 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS644638 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS648009 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS648034 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS648691 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS648715 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS648758 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal (HER2+) from ORIGENE TECHNOLOGIES | CS804205 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CS651508 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal (HER2+) from ORIGENE TECHNOLOGIES | CS520963 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Breast; Adenocarcinoma of breast, ductal (HER2+) from ORIGENE TECHNOLOGIES | CS544929 | 5x5um | ORIGENE TECHNOLOGIES |
| Phosphoserine aminotransferase 1 (PSAT1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409248 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphoserine phosphatase (PSPH) from ORIGENE TECHNOLOGIES | LY417896 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphoseryl-tRNA kinase (PSTK) from ORIGENE TECHNOLOGIES | LY407055 | 100 ug | ORIGENE TECHNOLOGIES |
| Human MAD1 mitotic arrest deficient-like 1 (yeast) (MAD1L1), transcript variant 2 from ORIGENE TECHNOLOGIES | TP322718 | 20 ug | ORIGENE TECHNOLOGIES |
| Human MAD2 mitotic arrest deficient-like 2 (yeast) (MAD2L2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP325253 | 20 ug | ORIGENE TECHNOLOGIES |
| Complement component 1, r subcomponent (C1R) from ORIGENE TECHNOLOGIES | LY400654 | 100 ug | ORIGENE TECHNOLOGIES |
| Complement component 1, r subcomponent-like (C1RL) from ORIGENE TECHNOLOGIES | LY402565 | 100 ug | ORIGENE TECHNOLOGIES |
| Complement component 1, s subcomponent (C1S), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404424 | 100 ug | ORIGENE TECHNOLOGIES |
| Complement component 1, s subcomponent (C1S), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400655 | 100 ug | ORIGENE TECHNOLOGIES |
| DENND6A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407268 | 1 kit | ORIGENE TECHNOLOGIES |
| DENND1A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407881 | 1 kit | ORIGENE TECHNOLOGIES |
| DENND4A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408079 | 1 kit | ORIGENE TECHNOLOGIES |
| DENND5A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409850 | 1 kit | ORIGENE TECHNOLOGIES |
| DENND2A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN420073 | 1 kit | ORIGENE TECHNOLOGIES |
| Dennd1a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504487 | 1 kit | ORIGENE TECHNOLOGIES |
| Dennd2a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504490 | 1 kit | ORIGENE TECHNOLOGIES |
| Dennd4a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504494 | 1 kit | ORIGENE TECHNOLOGIES |
| Dennd5a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504497 | 1 kit | ORIGENE TECHNOLOGIES |
| Dennd6a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504499 | 1 kit | ORIGENE TECHNOLOGIES |
| Human EPH receptor A1 (EPHA1) from ORIGENE TECHNOLOGIES | TP313689 | 20 ug | ORIGENE TECHNOLOGIES |
| Human EPH receptor A1 (EPHA1) from ORIGENE TECHNOLOGIES | TP700137 | 20 ug | ORIGENE TECHNOLOGIES |
| Human EPH receptor A2 (EPHA2) from ORIGENE TECHNOLOGIES | TP305725 | 20 ug | ORIGENE TECHNOLOGIES |
| Human EPH receptor A7 (EPHA7) from ORIGENE TECHNOLOGIES | TP326293 | 20 ug | ORIGENE TECHNOLOGIES |
| Human EPH receptor A7 (EPHA7) from ORIGENE TECHNOLOGIES | TP700144 | 20 ug | ORIGENE TECHNOLOGIES |
| Human EPH receptor A2 (EPHA2) from ORIGENE TECHNOLOGIES | TP700138 | 20 ug | ORIGENE TECHNOLOGIES |